Viewing Study NCT05700656


Ignite Creation Date: 2025-12-24 @ 11:15 PM
Ignite Modification Date: 2025-12-25 @ 8:52 PM
Study NCT ID: NCT05700656
Status: RECRUITING
Last Update Posted: 2024-07-22
First Post: 2023-01-03
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Galunisertib Combined With Capecitabine in Advanced CRC With PM
Sponsor: The Netherlands Cancer Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module